JP Stock MarketDetailed Quotes

4521 Kaken Pharmaceutical

Watchlist
  • 4010.0
  • +10.0+0.25%
20min DelayNot Open May 9 15:30 JST
184.22BMarket Cap18.86P/E (Static)

Kaken Pharmaceutical Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
Total revenue
32.97%24.62B
0.57%18.25B
-1.29%72.04B
-0.30%17.36B
-1.28%18.51B
-3.23%18.02B
-0.26%18.15B
-4.01%72.98B
-4.99%17.41B
-6.79%18.75B
Cost of revenue
13.77%9.53B
1.33%8.2B
0.23%33.51B
3.11%8.68B
-2.37%8.38B
0.98%8.36B
-0.77%8.09B
-2.99%33.43B
-4.00%8.42B
-5.75%8.58B
Gross profit
48.82%15.09B
-0.04%10.05B
-2.57%38.54B
-3.49%8.68B
-0.34%10.14B
-6.60%9.66B
0.16%10.06B
-4.86%39.56B
-5.89%8.99B
-7.67%10.18B
Operating expense
36.42%9.25B
7.97%7.3B
-8.02%29.02B
-39.96%8.04B
13.17%6.78B
20.18%7.44B
13.02%6.76B
28.75%31.55B
109.83%13.39B
-2.89%5.99B
Staff costs
-3.52%1.7B
-2.97%1.73B
-0.99%7.12B
1.87%1.85B
-1.34%1.76B
-3.57%1.73B
-0.94%1.78B
-2.88%7.19B
-2.94%1.82B
-2.46%1.79B
Research and development costs
65.85%4.58B
15.31%3B
-20.56%12.54B
-57.37%4.04B
39.60%2.76B
36.43%3.14B
28.08%2.6B
87.52%15.79B
297.44%9.48B
-2.32%1.98B
Depreciation and amortization
----
----
8.93%317M
----
----
----
----
12.79%291M
----
----
-Depreciation
----
----
8.93%317M
----
----
----
----
12.79%291M
----
----
Other operating expenses
31.54%2.97B
8.15%2.57B
9.18%9.04B
1.61%1.83B
1.30%2.25B
22.65%2.58B
10.50%2.38B
-1.71%8.28B
-3.48%1.8B
-3.72%2.23B
Operating profit
73.82%5.84B
-16.48%2.75B
18.93%9.52B
114.59%641M
-19.69%3.36B
-46.54%2.22B
-18.80%3.3B
-53.11%8B
-238.35%-4.39B
-13.75%4.19B
Net non-operating interest income (expenses)
700.00%18M
50.00%-1M
10.00%-9M
33.33%-2M
-50.00%-3M
0.00%-2M
33.33%-2M
9.09%-10M
25.00%-3M
0.00%-2M
Non-operating interest income
1,150.00%25M
100.00%4M
14.29%8M
0.00%2M
0.00%2M
0.00%2M
100.00%2M
16.67%7M
100.00%2M
0.00%2M
Non-operating interest expense
40.00%7M
25.00%5M
0.00%17M
-20.00%4M
25.00%5M
0.00%4M
0.00%4M
0.00%17M
0.00%5M
0.00%4M
Net investment income
86.54%388M
35.90%265M
-4.41%412M
75.00%7M
7.22%208M
-50.00%2M
-14.85%195M
20.06%431M
150.00%4M
22.01%194M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
531M
-605M
1,200.00%13M
9M
0
0.00%1M
0
0
Income from associates and other participating interests
Special income (charges)
-21.05%-23M
10.81%-33M
90.29%-188M
93.75%-100M
-111.11%-19M
-700.00%-32M
88.54%-37M
47.05%-1.94B
57.79%-1.6B
18.18%-9M
Less:Other special charges
21.05%23M
-10.81%33M
128.38%169M
92.86%81M
111.11%19M
700.00%32M
94.74%37M
-88.86%74M
-94.74%42M
-18.18%9M
Less:Write off
----
----
-98.98%19M
-98.78%19M
----
----
--0
-37.78%1.86B
-47.93%1.56B
--0
Other non-operating income (expenses)
106.67%31M
-300.00%-4M
-82.93%57M
-85.47%25M
-65.91%15M
-78.26%15M
-95.92%2M
158.91%334M
207.14%172M
100.00%44M
Income before tax
90.51%6.79B
-31.30%2.37B
43.70%9.8B
109.89%576M
-19.27%3.56B
-47.71%2.21B
-13.90%3.45B
-50.90%6.82B
-918.18%-5.82B
-12.13%4.41B
Income tax
98.64%1.9B
-34.36%617M
28.54%1.77B
63.36%-775M
-22.17%955M
-44.21%650M
-14.55%940M
-68.24%1.38B
-1,792.00%-2.12B
-18.04%1.23B
Net income
87.53%4.89B
-30.12%1.75B
47.52%8.03B
136.40%1.35B
-18.15%2.61B
-49.04%1.56B
-13.66%2.51B
-43.03%5.44B
-432.14%-3.71B
-9.65%3.19B
Net income continuous operations
87.53%4.89B
-30.15%1.75B
47.54%8.03B
136.42%1.35B
-18.15%2.61B
-49.05%1.56B
-13.65%2.51B
-43.03%5.44B
-432.14%-3.71B
-9.62%3.19B
Noncontrolling interests
0
0
0
0
0
0
Net income attributable to the company
87.53%4.89B
-30.12%1.75B
47.52%8.03B
136.40%1.35B
-18.15%2.61B
-49.04%1.56B
-13.66%2.51B
-43.03%5.44B
-432.14%-3.71B
-9.65%3.19B
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
87.53%4.89B
-30.12%1.75B
47.52%8.03B
136.40%1.35B
-18.15%2.61B
-49.04%1.56B
-13.66%2.51B
-43.03%5.44B
-432.14%-3.71B
-9.65%3.19B
Gross dividend payment
Basic earnings per share
87.29%129.08
-30.86%46.32
46.87%212.67
136.11%35.57
-18.89%68.92
-49.42%41.19
-12.90%66.99
-42.41%144.8
-447.89%-98.51
-8.80%84.97
Diluted earnings per share
87.50%129.08
-30.86%46.32
46.87%212.67
135.94%35.57
-18.98%68.841
-49.42%41.19
-12.90%66.99
-42.41%144.8
-437.04%-98.9781
-8.80%84.97
Dividend per share
0
0
0.00%150
0.00%75
0
0.00%75
0
0.00%150
0.00%75
0
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q3)Dec 31, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022
Total revenue 32.97%24.62B0.57%18.25B-1.29%72.04B-0.30%17.36B-1.28%18.51B-3.23%18.02B-0.26%18.15B-4.01%72.98B-4.99%17.41B-6.79%18.75B
Cost of revenue 13.77%9.53B1.33%8.2B0.23%33.51B3.11%8.68B-2.37%8.38B0.98%8.36B-0.77%8.09B-2.99%33.43B-4.00%8.42B-5.75%8.58B
Gross profit 48.82%15.09B-0.04%10.05B-2.57%38.54B-3.49%8.68B-0.34%10.14B-6.60%9.66B0.16%10.06B-4.86%39.56B-5.89%8.99B-7.67%10.18B
Operating expense 36.42%9.25B7.97%7.3B-8.02%29.02B-39.96%8.04B13.17%6.78B20.18%7.44B13.02%6.76B28.75%31.55B109.83%13.39B-2.89%5.99B
Staff costs -3.52%1.7B-2.97%1.73B-0.99%7.12B1.87%1.85B-1.34%1.76B-3.57%1.73B-0.94%1.78B-2.88%7.19B-2.94%1.82B-2.46%1.79B
Research and development costs 65.85%4.58B15.31%3B-20.56%12.54B-57.37%4.04B39.60%2.76B36.43%3.14B28.08%2.6B87.52%15.79B297.44%9.48B-2.32%1.98B
Depreciation and amortization --------8.93%317M----------------12.79%291M--------
-Depreciation --------8.93%317M----------------12.79%291M--------
Other operating expenses 31.54%2.97B8.15%2.57B9.18%9.04B1.61%1.83B1.30%2.25B22.65%2.58B10.50%2.38B-1.71%8.28B-3.48%1.8B-3.72%2.23B
Operating profit 73.82%5.84B-16.48%2.75B18.93%9.52B114.59%641M-19.69%3.36B-46.54%2.22B-18.80%3.3B-53.11%8B-238.35%-4.39B-13.75%4.19B
Net non-operating interest income (expenses) 700.00%18M50.00%-1M10.00%-9M33.33%-2M-50.00%-3M0.00%-2M33.33%-2M9.09%-10M25.00%-3M0.00%-2M
Non-operating interest income 1,150.00%25M100.00%4M14.29%8M0.00%2M0.00%2M0.00%2M100.00%2M16.67%7M100.00%2M0.00%2M
Non-operating interest expense 40.00%7M25.00%5M0.00%17M-20.00%4M25.00%5M0.00%4M0.00%4M0.00%17M0.00%5M0.00%4M
Net investment income 86.54%388M35.90%265M-4.41%412M75.00%7M7.22%208M-50.00%2M-14.85%195M20.06%431M150.00%4M22.01%194M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets 531M-605M1,200.00%13M9M00.00%1M00
Income from associates and other participating interests
Special income (charges) -21.05%-23M10.81%-33M90.29%-188M93.75%-100M-111.11%-19M-700.00%-32M88.54%-37M47.05%-1.94B57.79%-1.6B18.18%-9M
Less:Other special charges 21.05%23M-10.81%33M128.38%169M92.86%81M111.11%19M700.00%32M94.74%37M-88.86%74M-94.74%42M-18.18%9M
Less:Write off ---------98.98%19M-98.78%19M----------0-37.78%1.86B-47.93%1.56B--0
Other non-operating income (expenses) 106.67%31M-300.00%-4M-82.93%57M-85.47%25M-65.91%15M-78.26%15M-95.92%2M158.91%334M207.14%172M100.00%44M
Income before tax 90.51%6.79B-31.30%2.37B43.70%9.8B109.89%576M-19.27%3.56B-47.71%2.21B-13.90%3.45B-50.90%6.82B-918.18%-5.82B-12.13%4.41B
Income tax 98.64%1.9B-34.36%617M28.54%1.77B63.36%-775M-22.17%955M-44.21%650M-14.55%940M-68.24%1.38B-1,792.00%-2.12B-18.04%1.23B
Net income 87.53%4.89B-30.12%1.75B47.52%8.03B136.40%1.35B-18.15%2.61B-49.04%1.56B-13.66%2.51B-43.03%5.44B-432.14%-3.71B-9.65%3.19B
Net income continuous operations 87.53%4.89B-30.15%1.75B47.54%8.03B136.42%1.35B-18.15%2.61B-49.05%1.56B-13.65%2.51B-43.03%5.44B-432.14%-3.71B-9.62%3.19B
Noncontrolling interests 000000
Net income attributable to the company 87.53%4.89B-30.12%1.75B47.52%8.03B136.40%1.35B-18.15%2.61B-49.04%1.56B-13.66%2.51B-43.03%5.44B-432.14%-3.71B-9.65%3.19B
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders 87.53%4.89B-30.12%1.75B47.52%8.03B136.40%1.35B-18.15%2.61B-49.04%1.56B-13.66%2.51B-43.03%5.44B-432.14%-3.71B-9.65%3.19B
Gross dividend payment
Basic earnings per share 87.29%129.08-30.86%46.3246.87%212.67136.11%35.57-18.89%68.92-49.42%41.19-12.90%66.99-42.41%144.8-447.89%-98.51-8.80%84.97
Diluted earnings per share 87.50%129.08-30.86%46.3246.87%212.67135.94%35.57-18.98%68.841-49.42%41.19-12.90%66.99-42.41%144.8-437.04%-98.9781-8.80%84.97
Dividend per share 000.00%1500.00%7500.00%7500.00%1500.00%750
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve Show More